MRI-guided laser treatment for prostate cancer
Part of Cancer, Kidney & urinary clinical trials.
This trial tests a minimally invasive prostate treatment using MRI guidance and a focal laser to destroy only the cancer spot (not the whole prostate). If you have low-to-intermediate risk, MRI-visible prostate cancer in a limited area, it may help control the cancer while potentially reducing treatment side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a man age 40 to 80.
- Your prostate cancer is confirmed by biopsy and is low-to-intermediate risk (Gleason score 7 or less, with the main grade 4 or less).
- Your MRI shows one small suspicious tumor area (less than 20 mm), and that same area matches a positive biopsy spot.
- Your PSA blood test is below 15 ng/mL, and your cancer stage is T1c or T2.
- You can have MRI scans (no MRI-incompatible devices/metal) and you can complete the study questionnaires.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new way to treat intermediate-risk prostate cancer using a targeted laser guided by micro-ultrasound and MRI. It aims to see if this less invasive approach is safe and effective for men who have not had prior prostate cancer treatments.
This trial tests if giving fewer radiation treatments using a special MRI-guided machine is safe and effective for men with prostate cancer. It may help reduce side effects while still controlling the cancer.
This trial tests whether a precisely targeted laser procedure—guided by MRI images—can treat prostate cancer. It may help some men who have a certain type and location of tumor while aiming to avoid nearby sensitive structures.
This trial tests a laser procedure done through the skin between the scrotum and anus, guided by MRI and ultrasound, for men with certain prostate cancer types. It aims to heat and treat prostate cancer while checking safety and outcomes over follow-up visits.
This trial tests a laser treatment to destroy cancer cells in the prostate for people with early-stage prostate cancer who choose not to have surgery. It aims to target only the cancer while sparing healthy tissue.
This trial tests whether using MRI scans to guide radiation can allow lower doses to the healthy parts of the prostate, potentially reducing side effects. It is for men with intermediate- or high-risk prostate cancer that can be seen on MRI and has not spread.
Hear when a new Prostate cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.